Gastric Cancer Screening Quality Improvement System Establishment
A Prospective Cohort Study for Development of Korean Gastric Cancer Prediction Model and Tailored Gastric Cancer Screening Program
1 other identifier
observational
17
1 country
1
Brief Summary
Experienced endoscopists will perform endoscopy during the study period and the detection rate of gastric premalignant lesion, correlation between endoscopic and serologic diagnosis of premalignant lesions and inter-observer agreement rate will be analyzed before and after the education.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
March 25, 2015
CompletedFirst Posted
Study publicly available on registry
May 29, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedApril 18, 2016
April 1, 2016
12.1 years
March 25, 2015
April 14, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Detection rate for gastric premalignant lesion
7 years
Secondary Outcomes (4)
Correlation between endoscopic and serologic diagnosis of premalignant lesions
7 years
Inter-observer agreement rate for the diagnosis of premalignant lesions
2 months
Detection rate for gastric cancer
7 years
Detection rate for gastric dysplasia
7 years
Study Arms (1)
Experienced endoscopists
All the experienced endoscopists will receive education and feedback on the diagnosis for premalignant lesion of chronic atrophic gastritis and intestinal metaplasia
Interventions
Experienced endoscopists will receive education on Kimura-Takemoto classification and feedback for their answers for classification tests.
Eligibility Criteria
Patients who received colonoscopy in Seoul National University Hospital Healthcare System Gangnam Center from 2008 till 2020.
You may qualify if:
- Patients who received endoscopy in Seoul National University Hospital Healthcare System Gangnam Center from 2008 till 2020.
You may not qualify if:
- Age \< 18 years
- Those who refused to be included in the research
- History of gastric cancer
- Current medication with proton pump inhibitor, non-steroidal anti-inflammatory drug or aspirin
- Active/healing stage of gastric ulcer or gastric ulcer scar
- Active/healing stage of duodenal ulcer
- History of previous surgical or endoscopic resection of stomach
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Healthcare System Gangnam Center, Seoul National University Hospital
Seoul, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Su Jin Chung, MD.PhD.
Department of Internal Medicine and Healthcare Research Institute, Healthcare System Gangnam Center, Seoul National University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associated Professor
Study Record Dates
First Submitted
March 25, 2015
First Posted
May 29, 2015
Study Start
March 1, 2008
Primary Completion
April 1, 2020
Study Completion
December 1, 2020
Last Updated
April 18, 2016
Record last verified: 2016-04